SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

CytomX Therapeutics, Inc. (CTMX)

CTMX RSS Feed
Add CTMX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/8/2017 10:08:54 PM - Followers: 3 - Board type: Free - Posts Today: 0

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition, it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., ImmunoGen, Inc., and The University of Texas M. D. Anderson Cancer Center to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
CTMX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTMX News: Statement of Changes in Beneficial Ownership (4) 08/11/2017 12:52:21 PM
CTMX News: Statement of Changes in Beneficial Ownership (4) 08/11/2017 12:51:30 PM
CTMX News: CytomX to Present at the 2017 Wedbush PacGrow Healthcare Conference 08/10/2017 04:05:00 PM
CTMX News: Quarterly Report (10-q) 08/07/2017 04:21:10 PM
CTMX News: Current Report Filing (8-k) 08/07/2017 04:08:23 PM